Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Panretin®(alitretinoin)gel 0.1%(For topical use only)
Medication labelWhy this: Advisory · dailymed-prescription
Panretin® gel is indicated for topical treatment of cutaneous lesions in patients with AIDS-related Kaposi’s sarcoma. Panretin® gel is not indicated when systemic anti-KS therapy is required (e.g., more than 10 new KS lesions in the prior month, symptomatic lymphedema, symptomatic pulmonary KS, or symptomatic visceral involvement). There is no experience to date using Panretin® gel with systemic anti-KS treatment.
- generic_name
- alitretinoin
- brand_name
- Panretin
- product_names
- alitretinoin, Panretin
- ndc
- 64365-501, 64365-501-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en